Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2007
03/15/2007WO2007030290A2 Cristin/r-spondin ligands active in the wnt signaling pathway and methods, compositions and kits relating thereto
03/15/2007WO2007029361A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
03/15/2007WO2007029249A2 Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases
03/15/2007WO2006132925A3 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
03/15/2007WO2005117990A3 Compositions and methods for treatment of vascular grafts
03/15/2007WO2005112636A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF PRIMATE POLYOMAVIRUS GENES
03/15/2007WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide
03/15/2007WO2003082006A3 Methods and compositions for preventing obesity and obesity related disorders
03/15/2007WO2003068169A3 Stabilized synthetic immunogen delivery system
03/15/2007US20070061920 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
03/15/2007US20070061901 Methods to inhibit growth of prostate cancer cells
03/15/2007US20070060540 Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
03/15/2007US20070060539 Shc proteins as therapeutic targets in proliferative diseases
03/15/2007US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/15/2007US20070060537 Methods and compositions for inhibiting viral infections
03/15/2007US20070060536 Novel reagent compounds and methods of making and using the same
03/15/2007US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy
03/15/2007US20070059836 Genetic engineering; preventing the proliferation of neoplastic cells; cancer;
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
03/15/2007US20070059829 Invention relates to finding that Cristin/R-spondin family of heparin-binding proteins function as Fzd8/LRP6 receptors and induce beta -catenin/TCF-dependent gene activation via Wnt signaling pathway, instrumental in regulation of cell proliferation, differentiation and morphogenesis
03/15/2007US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
03/15/2007US20070059758 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
03/15/2007US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
03/15/2007US20070059724 Novel compositions and methods for lymphoma and leukemia
03/15/2007US20070059684 Method of identifying an antiviral agent
03/15/2007US20070059353 Polyarginine-modified liposome having nuclear entry ability
03/15/2007US20070059325 Genetic vaccine against PWD circovirus
03/15/2007US20070059324 Circovirus sequences associated with piglet weight loss disease (PWD)
03/15/2007US20070059323 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
03/15/2007US20070059322 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
03/15/2007US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer
03/15/2007US20070059311 Regulation of the hedgehog signaling pathway and uses thereof
03/15/2007US20070059307 Biological products
03/15/2007US20070059294 Therapeutiv preparation for hematopoietic disease
03/15/2007US20070059291 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
03/15/2007US20070059290 Transcriptional regulation of target genes
03/15/2007US20070059289 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with Hsp20
03/15/2007US20070059288 Treatment for heart disease
03/15/2007US20070059287 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
03/15/2007US20070059286 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
03/15/2007US20070059283 Feline IL-18 nucleic acid molecules
03/15/2007US20070059282 Immunocytokine sequences and uses thereof
03/15/2007CA2808659A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
03/15/2007CA2621694A1 Pharmaceutical compositions for delivery of ribonucleic acid to a cell
03/15/2007CA2621055A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
03/14/2007EP1762619A2 Multiple-tumor aberrant growth genes
03/14/2007EP1762614A2 Tumor-specific promoters
03/14/2007EP1762611A1 Nucleic acid/enzyme complex
03/14/2007EP1762610A1 Truncated dance, dance complex and method of using these
03/14/2007EP1762244A1 Bmp-9 compositions for inducing differentiation of cholinergic neurons
03/14/2007EP1762243A1 Factor for regulation of neurite growth
03/14/2007EP1761635A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof
03/14/2007EP1761627A1 Cell-based therapies for ischemia
03/14/2007EP1761273A1 Treatment of non alcoholic steatotic hepatitis (nash)
03/14/2007EP1761251A1 Lipid nanoparticles as vehicles for nucleic acids, process for their preparation and use
03/14/2007EP1504098B1 A method for in vitro molecular evolution of protein function
03/14/2007EP1434878A4 Nucleic acid constructs capable of high efficiency delivery of polynucleotides into dna containing organelles and methods of utilizing same
03/14/2007EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
03/14/2007EP1227838B1 Melanoma vaccine and methods of making and using same
03/14/2007EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature
03/14/2007EP1196197B1 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
03/14/2007EP1178999B1 L-ribo-lna analogues
03/14/2007EP1133318B1 Supramolecular complexes containing therapeutic agents
03/14/2007EP1007697B1 Production of proteins in eggs
03/14/2007CN1929867A Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
03/14/2007CN1929866A Enzyme-prodrug therapy for prosthetic joint repair
03/14/2007CN1928089A Total genome of HIV virus
03/14/2007CN1927877A siRNA for inhibiting human Ezrin gene expression and expression carrier thereof
03/14/2007CN1927405A Combination immunizing preparation comprising recombinant plasmid and duplicate deficit type recombinant adenovirus
03/14/2007CN1927404A Application of siRNA inhibiting human Ezrin gene expression in esophagus cancer cell traveling invasion research
03/14/2007CN1927403A Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof
03/14/2007CN1927402A Construction and preparation of tumor target gene transmission non-viral vector
03/14/2007CN1927401A Self-assembly composite nano granule tumor vaccine and method for preparing same
03/14/2007CN1927386A Application of NYGGF5 protein and encoding gene thereof in preparation of medicine for inhibiting adipocyte differentiation
03/14/2007CN1304581C Compositions and methods for treating neurodegenerative diseases
03/14/2007CN1304579C Recombinant vaccine using flavivirus as vector
03/14/2007CN1304578C Ecdysone receptor-based inducible gene expression system
03/14/2007CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
03/14/2007CN1304559C Oncolytic microorganism expressing heat shock protein and its application
03/14/2007CN1304057C Target point for treating M2b type acute myelogenous leukemia
03/14/2007CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2
03/14/2007CN1304046C Liver cancer relative gene DLK1 and its use
03/14/2007CA2558601A1 Substance carrier using hollow nanoparticle of hepatitis b virus protein and liposome, and method of introducing substance into cell
03/13/2007US7189837 Cell surface molecule-induced macrophage activation
03/13/2007US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives
03/13/2007US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents
03/13/2007US7189705 Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
03/13/2007US7189569 Modulation of cell division by an early mitotic inhibitor protein
03/13/2007US7189562 Mononuclear phagocytes in therapeutic drug delivery
03/13/2007US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents
03/13/2007US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
03/13/2007US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
03/13/2007US7189525 Human enzymes of the metalloprotease family
03/13/2007US7189391 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of myopathies like muscular dystrophy, for improving transplantation success
03/13/2007CA2311641C Pseudo-type retroviral vectors with modifiable surface capsid proteins
03/13/2007CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use
03/13/2007CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna
03/13/2007CA2240494C Therapeutic molecules generated by trans-splicing
03/13/2007CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/09/2007WO2006026051A2 Selections of genes and methods of using the same for diagnosis, prognosis and for targeting the therapy of neuroblastoma
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 870